Results 11 to 20 of about 4,696 (201)

Nitroquinolones and nitroquinolines: syntheses and antitrypanosomal activity [PDF]

open access: yesMolecular Diversity
Nitroaromatic small molecules are established anti-infectives, including against trypanosomal diseases. Inspired by our previously identified suicide inhibitors of Mycobacterium tuberculosis (Mtb) decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1), we ...
Nguyen, Tina P   +7 more
core   +5 more sources

Enantiospecific antitrypanosomal in vitro activity of eflornithine. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2021
The polyamine synthesis inhibitor eflornithine is a recommended treatment for the neglected tropical disease Gambian human African trypanosomiasis in late stage.
Mikael Boberg   +5 more
doaj   +6 more sources

Antitrypanosomal activities of proteasome inhibitors [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2002
Seven peptidyl proteasome inhibitors were tested for in vitro activity against Trypanosoma brucei bloodstream forms. Two compounds showed activity in the low nanomolar range. In general, trypanosomes were more susceptible to the compounds than were human
Nkemngu-Njinkeng, Joseph   +7 more
core   +5 more sources

Novel antitrypanosomal agents

open access: yesExpert Opinion on Investigational Drugs, 2005
Trypanosomes are the causative agents of Chagas' disease in Central and South America and sleeping sickness in sub-Saharan Africa. The current chemotherapy of the human trypanosomiases relies on only six drugs, five of which were developed > 30 years ago.
Tyler, Kevin M.   +3 more
core   +4 more sources

In Vitro Antitrypanosomal and Antibacterial Activity of Aqueous, Hydroethanolic and Ethanolic Extracts of Rumex obtusifolius L. Leaf and Root [PDF]

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 138, Issue 5, May 2026.
ABSTRACT Plant extracts are an important raw material for the development of new drugs. Rumex obtusifolius L., popularly known as ‘bitter dock’, has significant pharmacological properties. This study evaluated the in vitro antitrypanosomal activity of aqueous, hydroethanolic and ethanolic extracts from the leaf and roots of R. obtusifolius L.
Gabriela K. Borges   +5 more
wiley   +2 more sources

Pyridyl‐Imidazopyridine Derivatives Displaying Submicromolar Activity Against Trypanosoma cruzi [PDF]

open access: yesChemMedChem, Volume 21, Issue 13, 14 July 2026.
Previously reported pyridyl‐thiazoles and highly active imidazopyridines against Trypanosoma cruzi inspired the design of a new series of pyridyl‐substituted imidazopyridines. Among the synthesized compounds, 5h emerged as the most promising derivative, displaying potent trypanocidal activity (EC50 = 0.16 μM), excellent selectivity (SI > 1250), and ...
Ana Carolina Rocha Barreto   +9 more
wiley   +2 more sources

Antiplasmodial and Antitrypanosomal Activity of Pyrethrins and Pyrethroids

open access: yesJournal of Agricultural and Food Chemistry, 2016
In a screen of 1800 plant and fungal extracts for antiplasmodial, antitrypanosomal, and leishmanicidal activity, the n-hexane extract of Chrysanthemum cinerariifolium (Trevir.) Vis. flowers showed strong activity against Plasmodium falciparum.
Marcel Kaiser (41510)   +5 more
core   +6 more sources

Antidesmone, a novel antitrypanosomal alkaloid

open access: yesPharmaceutical and pharmacological letters, 2001
Antidesmone, a novel acetogenic quinolone alkaloid from the African shrub Antidesma membranaceum, has been found to exhibit potent antitrypanosomal activity against Trypanasoma cruzi, the pathogenic agent of Chagas disease.
Schlauer, J.   +6 more
core   +7 more sources

Antitrypanosomal Chloronitrobenzamides

open access: yesJournal of Medicinal Chemistry
Human African trypanosomiasis (HAT), a neglected tropical disease caused by Trypanosoma brucei gambiense (Tbg) or Trypanosoma brucei rhodesiense (Tbr), remains a significant public health concern with over 55 million people at risk of infection.
Kirsten Gillingwater (349563)   +10 more
core   +4 more sources

Scalable Access to N‑Acylindole Linkages: Enabling the Synthesis of Antitrypanosomal Noncanonical Cyclic Peptides for Chagas Disease [PDF]

open access: yesAngewandte Chemie, Volume 138, Issue 15, 6 April 2026.
A gram‐scale supply of bulbiferamide A, which features a rare N‐acylindole linkage and possesses potent inhibitory activity against Trypanosoma cruzi epimastigotes (IC50 = 4.1 µM)—the causative parasite of Chagas disease—was successfully achieved. Moreover, the cyclization strategy developed in this study facilitated the synthesis of noncanonical ...
Jie Zhang, Hugh Nakamura
wiley   +3 more sources

Home - About - Disclaimer - Privacy